Rank 63 • Biotech & Discovery
Valo Health
Employs an integrated cloud platform that utilizes human data to discover and develop therapeutic small molecules.
Visit website- Signal Score
- 84.8
- Total raised
- $450M
- Stage
- Series C
- Founded
- 2019
- Headquarters
- Boston, USA
- Region
- North America
Their signal
Valo's Opal platform uses longitudinal human data to de-risk drug discovery. By focusing heavily on human biology over animal models early in the pipeline, it commands significant investment and validation.
Signal Score 84.8editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in Biotech & Discovery
Did we miss something?
Change, add or remove details on this company. Our desk reviews every request.
Figures are subjective research desk estimates compiled from public sources and refreshed monthly, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.